dimarts, 2 de setembre del 2014

Study: St. Jude's FFR helps boost stenting over drug therapy alone




Researchers report that St. Jude Medical's fractional flow reserve technology helps slash adverse events, especially urgent revascularizations, compared with medical therapy alone.





Study: St. Jude's FFR tech helps cut adverse events in half

St. Jude Medical

News Well, Clinical Trials, Cardiovascular, Drug-Eluting Stents, Vascular

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Cn58S6
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)